Skip to main content
. Author manuscript; available in PMC: 2019 Jun 15.
Published in final edited form as: J Neuroimmunol. 2018 Mar 17;319:80–92. doi: 10.1016/j.jneuroim.2018.03.009

Fig. 10.

Fig. 10

GM-CSF partially rescues hippocampal neurogenesis of AD mice. (A) Immunohistochemical detection of Dcx-labeled cells in the DG of the hippocampi from 7-month-old non-TG and AD mice treated with PBS or GM-CSF. Scale bar = 200 μm. (B) Quantification of numbers of Dcx-labeled cells in the granular cell layer (GCL) of the DG (n = 7 per group, 12 sections per brain). Data represent mean number of Dcx+ cells ± SEM, and p ≤ 0.05 compared to anon-Tg/PBS, bnon-Tg/GM-CSF, or cAD/PBS as determined by one-way ANOVA with Newman-Keuls post-hoc test.